Page 154 - pfizervax
P. 154

PF-07302048 (BNT162 RNA-Based COVID-19 Vaccines)
                   Protocol C4591001


                    Table 11.  Alert Rule: Further Action Is Taken if the Number of Severe Cases in the
                                Vaccine Group Is Greater Than or Equal to the Prespecified Alert Rule
                                Value (A)
                      Total    Prespecifie  If the True   If the True   If the True   If the True   If the True
                     Severe     d Alert      Ratio of     Ratio of      Ratio of     Ratio of      Ratio of
                     Cases    Rule Value   Severe Cases  Severe Cases  Severe Cases  Severe Cases  Severe Cases
                                 (A):      Between the   Between the   Between the   Between the   Between the
                               Number of   Vaccine and   Vaccine and   Vaccine and   Vaccine and   Vaccine and
                                Severe       Placebo      Placebo       Placebo      Placebo       Placebo
                              Cases in the   Groups Is   Groups Is     Groups Is    Groups Is     Groups Is
                                Vaccine        1:1,         1:1,          2:1,         3:1,          4:1,
                               Group to    Probability   Probability   Probability   Probability   Probability
                                Trigger     of A Being   of A or More  of A or More  of A or More  of A or More
                                Further    Observed in     Being         Being        Being         Being
                                Action     the Vaccine   Observed in   Observed in   Observed in   Observed in
                                             Group       the Vaccine   the Vaccine   the Vaccine   the Vaccine
                                                           Group        Group         Group        Group
                       2           2         25.00%        25.00%       44.49%        56.25%       64.00%
                       3           2         37.50%        50.00%       74.12%        84.38%       89.60%
                       4           3         25.00%        31.25%       59.32%        73.83%       81.92%
                       5           4         15.63%        18.75%       46.16%        63.28%       73.73%
                       6           4         23.44%        34.38%       68.10%        83.06%       90.11%
                       7           5         16.41%        22.66%       57.14%        75.64%       85.20%
                       8           6         10.94%        14.45%       46.90%        67.85%       79.69%
                       9           6         16.41%        25.39%       65.11%        83.43%       91.44%
                       10          7         11.72%        17.19%       56.02%        77.59%       87.91%
                       11          8          8.06%        11.33%       47.35%        71.33%       83.89%
                       12          8         12.08%        19.38%       63.25%        84.24%       92.74%
                       13          9          8.73%        13.34%       55.31%        79.40%       90.09%
                       14         10          6.11%        8.98%        47.66%        74.15%       87.02%
                       15         10          9.16%        15.09%       61.94%        85.16%       93.89%
                       16         11          6.67%        10.51%       54.81%        81.03%       91.83%
                       17         12          4.72%        7.17%        47.88%        76.53%       89.43%
                       18         13          3.27%        4.81%        41.34%        71.75%       86.71%
                       19         13          5.18%        8.35%        54.43%        82.51%       93.24%
                       20         14          3.70%        5.77%        48.06%        78.58%       91.33%
























                                                            Page 144
   149   150   151   152   153   154   155   156